Literature DB >> 4824049

Anemia of the regular hemodialysis patient and its treatment.

K M Koch, W D Patyna, S Shaldon, E Werner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4824049     DOI： 10.1159/000180353

Source DB:  PubMed          Journal:  Nephron        ISSN： 1660-8151            Impact factor:   2.847


× No keyword cloud information.
  4 in total

1.  [Plasma erythropoietin and hematocrit under the influence of chronic hemodialysis treatment (author's transl)].

Authors:  E Schulz; B Mödder; K Rath
Journal:  Klin Wochenschr       Date:  1977-01-15

Review 2.  Safety aspects of parenteral iron in patients with end-stage renal disease.

Authors:  G Sunder-Plassmann; W H Hörl
Journal:  Drug Saf       Date:  1997-10       Impact factor: 5.606

3.  Would artificial neural networks implemented in clinical wards help nephrologists in predicting epoetin responsiveness?

Authors:  Luca Gabutti; Nathalie Lötscher; Josephine Bianda; Claudio Marone; Giorgio Mombelli; Michel Burnier
Journal:  BMC Nephrol       Date:  2006-09-18       Impact factor: 2.388

4.  Adequate hemodialysis improves anemia by enhancing glucose-6-phosphate dehydrogenase activity in patients with end-stage renal disease.

Authors:  Mahmoud Husni Ayesh Haj Yousef; Ahnaf Bataineh; Elham Elamin; Yousef Khader; Khaldoon Alawneh; Mohamad Rababah
Journal:  BMC Nephrol       Date:  2014-09-26       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.